Istiratumab Biosimilar – Anti-ERBB3, IGF1R, CD221 mAb – Research Grade

Reference:
Product nameIstiratumab Biosimilar - Anti-ERBB3, IGF1R, CD221 mAb - Research Grade
SourceCAS 1509928-04-4
SpeciesHomo sapiens
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsIstiratumab,MM-005,MM-141,ERBB3, IGF1R, CD221,anti-ERBB3, IGF1R, CD221
ReferencePX-TA1381
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa -[scFv]2
ClonalityMonoclonal Antibody

Description of Istiratumab Biosimilar - Anti-ERBB3/IGF1R/CD221 mAb - Research Grade

General information on Anti-ERBB3/IGF1R/CD221[Homo sapiens] (Istiratumab) Monoclonal Antibody

Istiratumab is investigated for the treatment of Front-line Metastatic Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Istiratumab Biosimilar – Anti-ERBB3, IGF1R, CD221 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag
Antigen

Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag

PX-P4725 221$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 189$
Stable Isotope Labelled Istiratumab Biosimilar – Anti-ERBB3/IGF1R/CD221 mAb – Research Grade
SIL

Stable Isotope Labelled Istiratumab Biosimilar – Anti-ERBB3/IGF1R/CD221 mAb – Research Grade

PX-TA1381-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products